Long-Term Effect of Intravenous Iron on Overall Survival and Hospitalization in Patients with Heart Failure with Reduced Ejection Fraction, Iron Deficiency and Mild Renal Impairment: An Open-Label 5-Year Follow Up Observation

Journal Title: Journal of Clinical and Diagnostic Research - Year 2017, Vol 11, Issue 11

Abstract

Introduction: Iron Deficiency (ID) is associated with increased mortality rates in patients with Heart Failure with reduced Ejection Fraction (HFrEF), as well as a general increase in morbidity compared with patients with normal iron levels. Aim: To determine 5-year overall survival rates among HFrEF patients with ID anaemia and reduction in renal function treated with intravenous (IV) iron in a pilot study. Materials and Methods: In this randomized controlled pilot study with a 5 years follow up, 40 patients from the general population that spontaneously consulted the outpatient’s office of the cardiology section at the Hospital Alemán Buenos Aires with HFrEF, renal impairment, anaemia, and ID were enrolled into two groups (n= 20/group). For 5 weeks, one group received isotonic saline solution and the other received IV iron sucrose, 200mg weekly. Over a 5-year follow-up period, overall survival and the number of hospitalizations were recorded, as well as variables associated with iron status, anaemia, HFrEF severity and cardiac function, renal function and level of inflammation. Results: Among patients treated with IV iron sucrose, survival was 80% after 5 years, which was significantly greater than survival in the control group (45%, p<0.05 versus treated group). Throughout the study, there were fewer hospitalizations among patients treated with IV iron sucrose compared with those in the control group. After 5 years, 85% of patients in the control group had been hospitalized, more than four times than among iron-treated patients (p<0.01). Iron treatment also improved iron status, New York Heart Association class and renal function. Conclusion: IV iron treatment increased survival in patients with HFrEF, renal impairment and ID anaemia, as well as reducing the number of patients requiring hospitalization over 5 years.

Authors and Affiliations

JORGE EDUARDO TOBLLI, FEDERICO PABLO DI GENNARO

Keywords

Related Articles

Overview of the Therapeutic Effects of Origanum vulgare and Hypericum perforatum Based on Iran’s Ethnopharmacological Documents

Herbs have played an important role in the health and wellness of human beings. Nowadays, medicinal herbs are at the forefront of studies of medical science because of their importance in public health. Understanding the...

Understanding Cancer Stem Cells in Head and Neck Squamous Cell Carcinoma: A Critical Update in Development of New Approaches

ABSTRACT Cancer Stem Cells (CSCs) have an important role in Head and Neck Squamous Cell Carcinoma (HNSCC). HNSCC is considered as one of the major health problems throughout the world. These self-renewing cells are respo...

Neisseria Meningitidis Causing Multiple Cerebral Abscesses in Early Neonatal Period: Case Report and Review of Literature

Neisseria meningitidis is a rare cause of meningitis and septicemia in neonates. There are few published case reports of neonatal meningococcal meningitis complicated by subdural empyema, cerebral abscess and hydrocephal...

Adult Solid Hepatic Mesenchymal Hamartoma Masquerading as Malignancy

Solid Hepatic Mesenchymal Hamartoma (HMH) rarely occurs in adults. We report two cases of solid adult HMH. A 62-year-old female with right upper abdominal pain on Computed Tomography (CT) scan revealed a well defined het...

Are Indian Peacekeepers on Path to Mental Peace?

ABSTRACT Introduction: There is paucity of literature on mental morbidity of United Nations (UN) peace keeping soldiers. Peacekeeping mission implies overseas deployment, hostile and harsh conditions, armed conflict and...

Download PDF file
  • EP ID EP366433
  • DOI 10.7860/JCDR/2017/29940.10850
  • Views 21
  • Downloads 0

How To Cite

JORGE EDUARDO TOBLLI, FEDERICO PABLO DI GENNARO (2017). Long-Term Effect of Intravenous Iron on Overall Survival and Hospitalization in Patients with Heart Failure with Reduced Ejection Fraction, Iron Deficiency and Mild Renal Impairment: An Open-Label 5-Year Follow Up Observation. Journal of Clinical and Diagnostic Research, 11(11), 18-24. https://europub.co.uk/articles/-A-366433